Correlation Between Gender and Age with Umbers and Stone Size in Eswl Patients in Saiful Anwar General Hospital
DOI:
https://doi.org/10.61841/wa24et64Keywords:
ESWL, gender, age, numbers and stone sizeAbstract
The aim of this study was to know the correlation of gender and age with numbers of stone and stone size in ESWL patients in Saiful Anwar General Hospital within 3 years. This study uses ESWL medical records from January 2014 until December 2016 in Saiful Anwar General Hospital. Inclusion criteria include patients with urinary tract stone with complete data and grouped by gender, age, numbers of stone, stone size. Incomplete data were excluded from this study. This data was collected and analyzed with analytic descriptive with Chi-Square methods. There were 2027 ESWL patients. With male was 1371 patients (67.6%), and female 656 patients (32.4%). The most patient is 40-54 years old with 988 patients (48.7%). There is no correlation between gender with stone size (p=0.386). There is a correlation between gender and numbers of stone (p=0.000). There is a correlation between age with stone size (p=0.015). There is a correlation between age and numbers of stone (p=0.003). Most patients who have urinary tract stones was male. 40-54 years old was the most age of the patients. There is no correlation between gender with stone size. There is a correlation between gender and numbers of stone. There is a correlation between age with stone size. There is a correlation between age and numbers of stone.
Downloads
References
1. Segura JW, Preminger GM, Assimos DG, et al. Nephrolithiasis Clinical Guidelines Panel Summary Report on The Management of Staghorn Calculi. American Urological Association. 2013.
2. Endrika Noviandrini, Ponco Birowo, Nur Rasyid. Urinary stone characteristics of patients treated with extracorporeal shock wave lithotripsy in Cipto Mangunkusumo Hospital Jakarta. 2015.
3. Emil AT, Jack WMA. Smith’s General Urology Ed 18th. USA: Mc Graw Hill medical. 2013.
4. Satoshi, H. Kidney Stone Disease and Risk Factor of CHD. International Journal of Urology. 12(10):859-863. 2014.
5. Junuzovic D, Prstojevic JK, Hasanbegovic M, Lepara Z. Evaluation of extracorporeal shock wave lithotripsy (ESWL):efficacy in treatment of urinary system stones. Acta Inform Med;22(5):309-14). 2014.
6. Elkholy MM, Ismail H, Abdelkhalek MA, Badr MM, Elfeky MM. Efficacy of extracorporeal shocwave lithotripsy in ureteral stones. Uroll Ann;6(4):346-51. 2014.
7. Politis G, Griffith DP. ESWL: stone-free efficacy based upon stone size and location. World J Urol. ;5:225-
8. 2013
8. Pal RP, Mellon JK. Renal Stone Disease. Foundation Years;4(5):199-203. 2012
9. Kalbu DU, Golan S, Livne PM, Pode D, Duvdevani M, Lifshitz D. Urinary stone composition in Israel: current status and variation with age and gender-A bicenter study. J Endourol;27(12):1539-42. 2013
10. Menon M. Parilkar BG, Drach GW. Urinary Lithiasis: etiology, diagnosis, and medical management. In: Walsh CP, Retik AB, Vaughan ED, Wein AJ, editors. Cambell’s Urology. 11th ed. Philadelphia: WB Saunders p 2662-5. 2016.
11. Wu W, Yang B, Ou L, Liang Y, Wan S, Li S, et al. Urinary stone analysis on 12.846 patients: a report from a single center in China. Urolithiasis;42(1):39-43. 2014
12. Huang WY, Chen YF,Carter S, Chang HC, Lan CF, Huang KH. Epidemiology of upper urinary tract stone disease in a Taiwanese population: a natioinwide, population based study. J Urol;189(6):2158-63. 2013.
13. Burnett AL, Rodriguez R, Jarrett TW. Genitourinary system: male anatomy and physiology. In: Greenfield LJ, Mulholland MW, Oldham KT, Zelenock GB, Lilimoe KD, editors. Essentials of Surgery Scientific Principles and Practice. 2nd ed. New York: Lippincott Williams & Wilkins;p.1111–8. 2012.
14. Nowfar S, Pallazi-Churas K, Chang DC, Sur RL. The relationship of obesity and gender prevalence changes in United States inpatient nephrolithiasis. Urology;78(5):1029–33. 2011.
15. Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res;36(6):303–7. 2008.
16. Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A, et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol;67(4):750–63. 2015.
17. Pearle MS, Lotan Y. Urinary lithiasis: etiology, epidemiology, and pathogenesis. In: Wein AJ, Kavoussi LR, editors. Campbell-Walsh Urology. Philadelphia: Elsevier Saunders;p.1257-60. 2012.
18. Taylor EN, Curhan GC. Diet and fluid prescription in stone disease. Kidney Int;70(5):835-9. 2013.
19. Kato Y, Yamaguchi S, Kakizaki H, Yachiku S. Influence of estrus status on urinary chemical parameters related to urolithiasis. Urol Res;33(6):476-80. 2013
20. Turk C, Knoll T, Petrik A, Sarica K, Seitz C, Straub M. Indication for active stone removal and selections of procedures. In: EAU Guidelines on Urolithiasis. 2017.
21. Tarawneh E, Awad Z, Hani A, Haroun AA, Hadidy A, Mahafza W, et al. Factors affecting urinary calculi treatment by extracorporeal shock wave lithotripsy. Saudi J Kidney Dis Transpl;21(4):660-5.2013
22. Alizadeh, A., Kiavar, M., Assadian-Rad, M., Morady, B., Alasti, M., Sadeghi, A., Emkanjoo, Z.Evaluation of the patients with syncope during the first month after coronary artery bypass graft(2011) Journal of Cardiovascular Disease Research, 2 (3), pp. 186-189.
DOI: 10.4103/0975-3583.85267
23. Mikhalchenko, A.V., Mikhalchenko, V.F., Zhidovinov, A.V., Yarygina, E.N., Mikhalchenko, D.V.Useing the cytologic method for curing diseases of the oral cavity mucous membrane after prosthetics(2018) International Journal of Pharmaceutical Research, 10 (4), pp. 152-158. https://www.scopus.com/inward/record.uri?eid=2s2.085056145032&partnerID=40&md5=bf877d91c9bd f47a3b60a91b1bc73cd7
24. Trehan S, Sharma G, Misra A. "siRNA: Sojourn from Discovery to Delivery Challenges and Clinics." Systematic Reviews in Pharmacy 1.1 (2010), 1-16. Print. doi:10.4103/0975-8453.59507
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
